These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 19105201

  • 21. Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.
    Khattab MA, Eslam M, Aly MM, Shatat M, Hussen A, Moussa YI, Elsaghir G, Abdalhalim H, Aly A, Gaber S, Harrison SA.
    J Clin Gastroenterol; 2012; 46(10):871-9. PubMed ID: 22664476
    [Abstract] [Full Text] [Related]

  • 22. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis.
    Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, Fagà E, Silli B, Pagano G.
    Hepatology; 2003 Apr; 37(4):909-16. PubMed ID: 12668986
    [Abstract] [Full Text] [Related]

  • 23. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.
    Nobili V, Cutrera R, Liccardo D, Pavone M, Devito R, Giorgio V, Verrillo E, Baviera G, Musso G.
    Am J Respir Crit Care Med; 2014 Jan 01; 189(1):66-76. PubMed ID: 24256086
    [Abstract] [Full Text] [Related]

  • 24. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
    Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J.
    Hepatology; 2004 Jul 01; 40(1):46-54. PubMed ID: 15239085
    [Abstract] [Full Text] [Related]

  • 25. Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort.
    Kashyap SR, Diab DL, Baker AR, Yerian L, Bajaj H, Gray-McGuire C, Schauer PR, Gupta M, Feldstein AE, Hazen SL, Stein CM.
    Obesity (Silver Spring); 2009 Sep 01; 17(9):1696-701. PubMed ID: 19360015
    [Abstract] [Full Text] [Related]

  • 26. Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease.
    Nobili V, Carpino G, Alisi A, Franchitto A, Alpini G, De Vito R, Onori P, Alvaro D, Gaudio E.
    Hepatology; 2012 Dec 01; 56(6):2142-53. PubMed ID: 22467277
    [Abstract] [Full Text] [Related]

  • 27. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.
    Metabolism; 2013 Nov 01; 62(11):1651-61. PubMed ID: 23928105
    [Abstract] [Full Text] [Related]

  • 28. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese.
    Wong VW, Wong GL, Yu J, Choi PC, Chan AW, Chan HY, Chu ES, Cheng AS, Chim AM, Chan FK, Sung JJ, Chan HL.
    Am J Gastroenterol; 2010 Jan 01; 105(1):132-8. PubMed ID: 19809411
    [Abstract] [Full Text] [Related]

  • 29. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    Musso G, Gambino R, Bo S, Uberti B, Biroli G, Pagano G, Cassader M.
    Diabetes Care; 2008 Mar 01; 31(3):562-8. PubMed ID: 18056890
    [Abstract] [Full Text] [Related]

  • 30. Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.
    Domenici FA, Brochado MJ, Martinelli Ade L, Zucoloto S, da Cunha SF, Vannucchi H.
    Gene; 2013 Oct 25; 529(2):326-31. PubMed ID: 23891824
    [Abstract] [Full Text] [Related]

  • 31. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.
    Saadi H, Nagelkerke N, Carruthers SG, Benedict S, Abdulkhalek S, Reed R, Lukic M, Nicholls MG.
    Diabetes Res Clin Pract; 2008 Jun 25; 80(3):392-8. PubMed ID: 18282631
    [Abstract] [Full Text] [Related]

  • 32. Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.
    Kahraman A, Sowa JP, Schlattjan M, Sydor S, Pronadl M, Wree A, Beilfuss A, Kilicarslan A, Altinbaş A, Bechmann LP, Syn WK, Gerken G, Canbay A.
    Clin Sci (Lond); 2013 Oct 25; 125(8):391-400. PubMed ID: 23627434
    [Abstract] [Full Text] [Related]

  • 33. TCF7L2 polymorphism rs7903146 and predisposition for type 2 diabetes mellitus in obese children.
    Roth CL, Hinney A, Reinehr T, Schreiner F, Nguyen TT, Müller T, Scholl C, Woelfle J, Karpushova A, Schäfer H, Nöthen MM, Hebebrand J.
    Horm Metab Res; 2008 Oct 25; 40(10):713-7. PubMed ID: 18546086
    [Abstract] [Full Text] [Related]

  • 34. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.
    Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE.
    Hepatology; 2006 Jul 25; 44(1):27-33. PubMed ID: 16799979
    [Abstract] [Full Text] [Related]

  • 35. rs7903146 (C/T) polymorphism of Transcription factor 7 like 2 (TCF7L-2) gene is independently associated with non-alcoholic fatty liver disease in Asian Indians.
    Bhatt SP, Misra A, Pandey RM.
    Diabetes Metab Syndr; 2020 Jul 25; 14(3):175-180. PubMed ID: 32142998
    [Abstract] [Full Text] [Related]

  • 36. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F.
    Ren Fail; 2007 Jul 25; 29(2):147-54. PubMed ID: 17365928
    [Abstract] [Full Text] [Related]

  • 37. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
    Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Pennell CE, de Klerk N, Oddy WH, Shipman P, Adams LA.
    Hepatology; 2011 Mar 25; 53(3):800-9. PubMed ID: 21374659
    [Abstract] [Full Text] [Related]

  • 38. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
    Yoneda M, Iwasaki T, Fujita K, Kirikoshi H, Inamori M, Nozaki Y, Maeyama S, Wada K, Saito S, Terauchi Y, Nakajima A.
    Alcohol Clin Exp Res; 2007 Jan 25; 31(1 Suppl):S15-21. PubMed ID: 17331160
    [Abstract] [Full Text] [Related]

  • 39. Adiponectin, resistin and leptin response to dietary intervention in diabetic nephropathy.
    Kozłowska L, Rydzewski A, Fiderkiewicz B, Wasińska-Krawczyk A, Grzechnik A, Rosołowska-Huszcz D.
    J Ren Nutr; 2010 Jul 25; 20(4):255-62. PubMed ID: 20537918
    [Abstract] [Full Text] [Related]

  • 40. Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake.
    Musso G, Gambino R, De Michieli F, Biroli G, Premoli A, Pagano G, Bo S, Durazzo M, Cassader M.
    Am J Clin Nutr; 2007 Sep 25; 86(3):661-71. PubMed ID: 17823431
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.